Safety and Efficacy of Self-Administered Subcutaneous Immunoglobulin in Patients with Primary Immunodeficiency Diseases

Author： Ochs Hans   Gupta Sudhir   Kiessling Peter   Nicolay Uwe   Berger Melvin  

Publisher： Springer Publishing Company

ISSN： 0271-9142

Source： Journal of Clinical Immunology, Vol.26, Iss.3, 2006-05, pp. : 265-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases

By Kanegane Hirokazu   Imai Kohsuke   Yamada Masafumi   Takada Hidetoshi   Ariga Tadashi   Bexon Martin   Rojavin Mikhail   Hu Wilson   Kobayashi Midori   Lawo John-Philip   Nonoyama Shigeaki   Hara Toshiro   Miyawaki Toshio  

Journal of Clinical Immunology, Vol. 34, Iss. 2, 2014-02 ,pp. : 204-211

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

By Hagan John   Fasano Mary   Spector Sheldon   Wasserman Richard   Melamed Isaac   Rojavin Mikhail   Zenker Othmar   Orange Jordan  

Journal of Clinical Immunology, Vol. 30, Iss. 5, 2010-09 ,pp. : 734-745

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Tolerability of an Argentine Intravenous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases

By Krasovec S.   Ornani A.   Oleastro M.   Rosenzweig S.   Roy A.   Perez L.   Campos G.   MarÍn N.   Martinez A.   Mahieu C.   Manfredi M.   Sisti A.   Zelazko M.  

Journal of Clinical Immunology, Vol. 27, Iss. 2, 2007-03 ,pp. : 227-232

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter Crossover Comparison of the Safety and Efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in Patients with Primary Immunodeficiency Diseases

By Schiff Richard I.   Williams Larry W.   Nelson Robert P.   Buckley Rebecca H.   Burks Wesley   Good Robert A.  

Journal of Clinical Immunology, Vol. 17, Iss. 1, 1997-01 ,pp. : 21-28

Springer Publishing Company

Access to resources Recommend Favorite

Safety, Efficacy, and Pharmacokinetics of Flebogamma® 5% [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases

By Berger Melvin   Pinciaro Paul J.    

Journal of Clinical Immunology, Vol. 24, Iss. 4, 2004-07 ,pp. : 389-396

Springer Publishing Company

Access to resources Recommend Favorite